Search
IRadimed Corp
IRMDAdd to Watchlist
99.463USD
+1.423+1.45%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
1.27BMarket Cap
53.66P/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+1.45%
5 Days
+5.07%
1 Month
+8.05%
6 Months
+2.24%
Year to Date
+2.24%
1 Year
+64.38%
Key Figures
98.400Open
99.550High
73.04KVolume
53.66P/E TTM
41.76P/E Dynamic
0.710Dividend TTM
0.57%Turnover Ratio
98.040Prev. Close
96.800Low
5.47MTurnover
65.78P/E Static
12.86P/B
0.71%Div Yield TTM
21.85%ROA
107.90052wk High
0.91Volume Ratio
19.23MNet Profit
12.72MShares
1.8535EPS TTM
0.91Beta
25.04%ROE
53.13252wk Low
2.80%Amplitude
76.50%Gross Margin
1.27BMarket Cap
4.96Reward/Risk
1.84%Risk Rate
TradingKey Stock Score of IRadimed Corp
Currency: USD Updated: 2026-07-01Key Insights
IRadimed Corp's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 26 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 118.00.In the medium term, the stock price is expected to remain stable.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
IRadimed Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
IRadimed Corp Highlights
StrengthsRisks
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories and services. Its MRidium 3860+ MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gauss.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 27.84% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 83.81M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 83.81M.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 29.64%.
Overvalued
The company’s latest PE is 52.90, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 8.32M shares, decreasing 5.17% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 0.00 shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 1.34.
Analyst Rating
Based on
2
analysts
Buy
Current Rating
118.000
Target Price
+23.48%
Upside Space
IRadimed Corp News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
IRadimed Corp Info
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories and services. Its MRidium 3860+ MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gauss.
Ticker SymbolIRMD
CompanyIRadimed Corp
CEOSusi (Roger)
Websitehttps://www.iradimed.com/
Related Instruments
-0.47%
+2.14%
+3.75%
+4.88%
+1.94%
-1.15%
+4.36%
+4.28%
+5.65%
-0.07%
+1.59%
+6.00%
+1.33%
+2.31%
-2.91%
+2.48%
+2.63%
-0.52%
-0.58%
-0.95%Popular Instruments
52683.900
+429.600 (+0.82%)
29206.200
-593.100 (-1.99%)
7453.300
-22.200 (-0.30%)
14729.000
-626.000 (-4.08%)
67759.000
-1726.000 (-2.48%)
6337.800
+62.400 (+0.99%)
68.524
+0.556 (+0.82%)
308.310
+13.930 (+4.73%)
193.510
-4.070 (-2.06%)
4121.010
+90.240 (+2.24%)
FAQs
What is the current price of IRadimed Corp (IRMD)?
The current price of IRadimed Corp (IRMD) is 98.04.
What is the symbol of IRadimed Corp?
The ticker symbol of IRadimed Corp is IRMD.
What is the 52-week high of IRadimed Corp?
The 52-week high of IRadimed Corp is 107.90.
What is the 52-week low of IRadimed Corp?
The 52-week low of IRadimed Corp is 53.13.
What is the market capitalization of IRadimed Corp?
The market capitalization of IRadimed Corp is 1.25B.
Is IRadimed Corp (IRMD) currently rated as Buy, Hold, or Sell?
According to analysts, IRadimed Corp (IRMD) has an overall rating of Buy, with a price target of 118.00.
What is the Earnings Per Share (EPS TTM) of IRadimed Corp (IRMD)?
The Earnings Per Share (EPS TTM) of IRadimed Corp (IRMD) is 1.77.